UNSPSC 51393308: Laprafylline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51393308

Definition

This classification denotes a bronchodilator with the molecular formula C29H36N6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F427P36M7J, chemically known as 1-methyl-3-isobutyl-8-(2-ethyl(1-(4-diphenylmethylpiperazinyl)))-3,7-dihydro-(1h)-purine 2,6-dione but generally known as laprafylline, which bears US NIH Compound Identifier 65821. European Medicines Agency schedules Laprafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08405MIG.

Read the full definition

The term LAPRAFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). LAPRAFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule laprafylline under HS 29395900 and SITC 54145. As of Q4 2014, LAPRAFYLLINE remains the US FDA Preferred Term for this commodity. Laprafylline bears US NLM identifiers UMLS ID C0073782 and NCI Concept Code C96198. SMILES: O=C1N(C(=O)N(C2NC([NH]C12)CCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)CC(C)C)C.

About UNSPSC 51393308

UNSPSC 51393308 Laprafylline is a Commodity code showing minimal recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities posted under this code — Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems and the Texas Health and Human Services Commission's RFI on Direct-to-Manufacturer Prescriptions — address pharmaceutical products and pharmacy benefit management rather than laprafylline specifically. State and local governments do not appear to be actively soliciting laprafylline as a standalone pharmaceutical under this code at present.

The mismatch between the code's nominal scope and actual recent activity suggests either misclassification by issuing bodies or discontinuation of routine procurement in this category. The Seminole County opportunity targets naloxone and drug deactivation systems through quarterly competitive bidding for community health support, while the Texas HHS RFI explores vendor capabilities for direct manufacturer contracting outside traditional pharmacy benefit manager arrangements — neither directly concerns laprafylline procurement. Geographic activity, where detected, centers on Florida and Texas, but the limited volume and scope mismatch signal that this code warrants close monitoring rather than active pursuit at this time. Vendors in pharmaceutical supply should verify issuing-body coding practices before investing in pursuit strategy under this Commodity.

Quick answers

What is UNSPSC 51393308?

UNSPSC 51393308 is Laprafylline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51393308?

UNSPSC 51393308 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51393308

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code